Skip to content

A trial in patients suffering from a specific form of an eye disorder called retinitis pigmentosa

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504383-42-00
Acronym
VG901-2021 A
Enrollment
6
Registered
2023-06-29
Start date
2025-02-02
Completion date
Unknown
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa (due to CNGA1 mutation)

Interventions

None listed

Sponsors

VeonGen Therapeutics GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026